PROCEEDINGS VOLUME 6139
SPIE BIOS | 21-26 JANUARY 2006
Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XV
IN THIS VOLUME

0 Sessions, 38 Papers, 0 Presentations
PDT Effects  (3)
SPIE BIOS
21-26 January 2006
San Jose, California, United States
PDT Mechanisms
Proc. SPIE 6139, Cell death pathways associated with PDT, 613902 (15 February 2006); doi: 10.1117/12.639925
Proc. SPIE 6139, PDT-induced changes in light scattering from cells using lysosomal- vs. mitochondrial-localizing photosensitizers, 613903 (6 March 2006); doi: 10.1117/12.644907
Proc. SPIE 6139, Apoptotic inducing ability of a novel photosensitizing agent, Ge Sulfophthalocyanine on oesophageal and breast cancer cell lines, 613904 (6 March 2006); doi: 10.1117/12.641604
Proc. SPIE 6139, Utility of tumor-avid photosensitizers in developing bifunctional agents for tumor imaging and/or phototherapy, 613905 (6 March 2006); doi: 10.1117/12.647866
Proc. SPIE 6139, Photosensitizer decorated iron oxide nanoparticles: bimodal agent for combined hyperthermia and photodynamic therapy, 613906 (6 March 2006); doi: 10.1117/12.646341
ALA-sensitized PDT
Proc. SPIE 6139, ALA-based fluorescence diagnosis of malignant oral lesions in the presence of bacterial porphyrin formation, 613908 (6 March 2006); doi: 10.1117/12.646533
Proc. SPIE 6139, Nuclear transcription factors: a new approach to enhancing cellular responses to ALA-mediated photodynamic therapy, 613909 (6 March 2006); doi: 10.1117/12.646880
Proc. SPIE 6139, Analysis of cell line variation in biochemical production of protoporphyrin IX, 61390A (6 March 2006); doi: 10.1117/12.644787
Proc. SPIE 6139, Optical spectroscopy by 5-aminolevulinic acid hexylester induced photodynamic treatment in rat bladder cancer, 61390C (6 March 2006); doi: 10.1117/12.646463
PDT Effects
Proc. SPIE 6139, Ceramide accumulation after photosensitization is absent after the Bcl-2 Inhibitor HA14-1, 61390E (6 March 2006); doi: 10.1117/12.657692
Proc. SPIE 6139, Distribution studies of m-THPC after topical application of m-THPC thermogel in a murine non-melanoma skin cancer tumor model by fluorescence spectroscopic and imaging techniques, 61390G (6 March 2006); doi: 10.1117/12.646142
Proc. SPIE 6139, Design and verification of NIR DOT electro-optical measuring system, 61390H (6 March 2006); doi: 10.1117/12.645180
Clinical and Preclinical PDT
Proc. SPIE 6139, Evaluation of Tookad-mediated photodynamic effect on peripheral nerve in a canine model, 61390K (6 March 2006); doi: 10.1117/12.646317
Proc. SPIE 6139, In vivo light dosimetry of interstitial PDT of human prostate, 61390L (6 March 2006); doi: 10.1117/12.646220
Instrumentation I
Proc. SPIE 6139, Study of light fluence rate distribution in photodynamic therapy using finite-element method, 61390M (6 March 2006); doi: 10.1117/12.646251
Proc. SPIE 6139, Comparison of techniques for quantification of fluorescence from tissue, 61390N (6 March 2006); doi: 10.1117/12.647572
Proc. SPIE 6139, Diffuse reflectance spectra measured in vivo in human tissues during Photofrin-mediated pleural photodynamic therapy, 61390O (6 March 2006); doi: 10.1117/12.647016
Proc. SPIE 6139, Photosensitizer dosimetry controlled PDT treatment planning reduces inter-individual variability in response to PDT, 61390P (6 March 2006); doi: 10.1117/12.647439
Instrumentation II
Proc. SPIE 6139, NIR electro-optical measurement for pseudo-models of biological tissues, 61390R (6 March 2006); doi: 10.1117/12.645029
Proc. SPIE 6139, Measurement of fluorophore concentration in scattering media by one single optical fiber, 61390S (6 March 2006); doi: 10.1117/12.646144
Proc. SPIE 6139, Basic study on pulse-intensity-domain depth-controlled photodynamic therapy for transurethral prostate cancer, 61390T (6 March 2006); doi: 10.1117/12.647768
Proc. SPIE 6139, Mechanism of singlet oxygen chemiluminescence enhancement by human serum albumin, 61390U (6 March 2006); doi: 10.1117/12.643602
Proc. SPIE 6139, Efficacy of photodynamic inactivation against <i>Pseudomonas aeruginosa</i> with pulsed light and CW light excitation, 61390V (6 March 2006); doi: 10.1117/12.653078
New Directions
Proc. SPIE 6139, Photodynamic therapy for epilepsy, 61390W (6 March 2006); doi: 10.1117/12.648288
Proc. SPIE 6139, Synthesis, characterization, and preclinical studies of two-photon-activated targeted PDT therapeutic triads, 61390X (6 March 2006); doi: 10.1117/12.646312
Proc. SPIE 6139, Laser generation and detection of surface acoustic waves: used for breast cancer detection, 61390Y (6 March 2006); doi: 10.1117/12.637784
Poster Session
Proc. SPIE 6139, Analysis of the photodynamic therapy effects by using chloroaluminum phthalocyanine incorporated into liposomes and fractionation energy in colon tumors of rats, 613910 (6 March 2006); doi: 10.1117/12.644973
Proc. SPIE 6139, Investigation of photodynamic activity of water-soluble porphyrins in vitro and in vivo, 613911 (6 March 2006); doi: 10.1117/12.645053
Proc. SPIE 6139, A macro-Monte Carlo method for the simulation of diffuse light transport in tissue, 613913 (6 March 2006); doi: 10.1117/12.646048
Proc. SPIE 6139, Phototriggered multifunctional drug delivery device, 613914 (6 March 2006); doi: 10.1117/12.646298
Proc. SPIE 6139, Synthesis and photodynamic activities of modified corrole derivatives on nasopharyngeal carcinoma cells, 613915 (6 March 2006); doi: 10.1117/12.646328
Proc. SPIE 6139, Comparison between mALA- and ALA-PDT in the treatment of basal cell carcinomas, 613917 (6 March 2006); doi: 10.1117/12.646563
Proc. SPIE 6139, System for providing simultaneous PDT delivery and dual spectroscopic monitoring in clinical basal cell carcinoma therapy, 613918 (6 March 2006); doi: 10.1117/12.646535
Proc. SPIE 6139, Optimum source design for detection of heterogeneities in diffuse optical imaging, 61391A (6 March 2006); doi: 10.1117/12.647209
Proc. SPIE 6139, Light dosimetry calculations for esophageal photodynamic therapy using porfimer sodium, 61391D (6 March 2006); doi: 10.1117/12.660155
Proc. SPIE 6139, Handheld dual fluorescence and reflection spectroscopy system for monitoring topical low dose ALA-PDT of actinic keratoses (AK), 61391E (6 March 2006); doi: 10.1117/12.661728
Proc. SPIE 6139, Sub-surface fluorescence imaging of Protoporphyrin IX with B-Scan mode tomography, 61391F (6 March 2006); doi: 10.1117/12.664717
Proc. SPIE 6139, Ru, Os, Rh mixed-metal complexes are a potential novel class of oxygen independent photosensitizers for PDT, 61391G (6 March 2006); doi: 10.1117/12.668630
Back to Top